Citron turns spotlight on Mallinckrodt, shares plunge
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Stressed Mallinckrodt (MNK) SOTP Suggests $70-$90/Share, Jefferies Says
November 10, 2015 7:24 AM ESTJefferies analyst Anthony Petrone provided stress test assumptions on Mallinckrodt plc (NYSE: MNK) following Citron Research short seller allegations.
Petrone notes shares were pressured on two items:
1) Concerns around the companys business model; and
2) Results of a pilot H.P. Acthar Gel presented at the ACR meeting.
The analyst highlighted the following:
Knowns on Acthar pricing and... More


